ADMA Biologics Reports Third Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire Inc. | Nov 4, 2026 4:05 PM EST

3Q 2026 Total Revenue of $141.1 Million, Increasing 5% Year-over-Year